BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34272920)

  • 41. Shear wave elastography prior to transjugular intrahepatic portosystemic shunt may predict the decrease in hepatic vein pressure gradient.
    Attia D; Rodt T; Marquardt S; Hinrichs J; Meyer BC; Gebel M; Wacker F; Manns MP; Potthoff A
    Abdom Radiol (NY); 2019 Mar; 44(3):1127-1134. PubMed ID: 30288582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation of aspartate aminotransferase/platelet ratio index with hepatic venous pressure gradient in cirrhosis.
    Verma V; Sarin SK; Sharma P; Kumar A
    United European Gastroenterol J; 2014 Jun; 2(3):226-31. PubMed ID: 25360306
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-invasive candidate protein signature predicts hepatic venous pressure gradient reduction in cirrhotic patients after sustained virologic response.
    Richards SM; Guo F; Zou H; Nigsch F; Baiges A; Pachori A; Zhang Y; Lens S; Pitts R; Finkel N; Loureiro J; Mongeon D; Ma S; Watkins M; Polus F; Albillos A; Tellez L; Martinez-González J; Bañares R; Turon F; Ferrusquía-Acosta J; Perez-Campuzano V; Magaz M; Forns X; Badman M; Sailer AW; Ukomadu C; Hernández-Gea V; Garcia-Pagán JC
    Liver Int; 2023 Sep; 43(9):1984-1994. PubMed ID: 37443448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No.
    Thalheimer U; Bellis L; Puoti C; Burroughs AK
    Eur J Intern Med; 2011 Feb; 22(1):5-7. PubMed ID: 21238884
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatic venous pressure gradient: Inaccurately estimates portal venous pressure gradient in alcoholic cirrhosis and portal hypertension.
    Zhang D; Wang T; Yue ZD; Wang L; Fan ZH; Wu YF; Liu FQ
    World J Gastrointest Surg; 2023 Nov; 15(11):2490-2499. PubMed ID: 38111777
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of hepatic steatosis on portal hypertension.
    Semmler G; Scheiner B; Schwabl P; Bucsics T; Paternostro R; Chromy D; Stättermayer AF; Trauner M; Mandorfer M; Ferlitsch A; Reiberger T
    PLoS One; 2019; 14(11):e0224506. PubMed ID: 31693695
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: A proof of concept study.
    Levick C; Phillips-Hughes J; Collier J; Banerjee R; Cobbold JF; Wang LM; Piechnik SK; Robson MD; Neubauer S; Barnes E; Pavlides M
    PLoS One; 2019; 14(8):e0221066. PubMed ID: 31430314
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A computational model of the hepatic circulation applied to analyze the sensitivity of hepatic venous pressure gradient (HVPG) in liver cirrhosis.
    Wang T; Liang F; Zhou Z; Shi L
    J Biomech; 2017 Dec; 65():23-31. PubMed ID: 29042056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatic venous pressure gradient as a predictor of fibrosis in chronic liver disease because of hepatitis B virus.
    Kumar M; Kumar A; Hissar S; Jain P; Rastogi A; Kumar D; Sakhuja P; Sarin SK
    Liver Int; 2008 May; 28(5):690-8. PubMed ID: 18433395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Evaluation and treatment of portal hypertension].
    Brůha R; Petrtýl J
    Cas Lek Cesk; 2016; 155(2):22-6. PubMed ID: 27088788
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of atorvastatin on portal hemodynamics and clinical outcomes in patients with cirrhosis with portal hypertension: a proof-of-concept study.
    Bishnu S; Ahammed SM; Sarkar A; Hembram J; Chatterjee S; Das K; Dhali GK; Chowdhury A; Das K
    Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):54-59. PubMed ID: 29099421
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis.
    Rincón D; Lo Iacono O; Tejedor M; Hernando A; Ripoll C; Catalina MV; Salcedo M; Matilla A; Senosiain M; Clemente G; Molinero LM; Albillos A; Bañares R
    Scand J Gastroenterol; 2013 Apr; 48(4):487-95. PubMed ID: 22871085
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study.
    Robic MA; Procopet B; Métivier S; Péron JM; Selves J; Vinel JP; Bureau C
    J Hepatol; 2011 Nov; 55(5):1017-24. PubMed ID: 21354450
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlation of transient elastography with hepatic venous pressure gradient in patients with cirrhotic portal hypertension: A study of 326 patients from India.
    Kumar A; Khan NM; Anikhindi SA; Sharma P; Bansal N; Singla V; Arora A
    World J Gastroenterol; 2017 Jan; 23(4):687-696. PubMed ID: 28216976
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of patients with decompensated cirrhosis at high risk for death: improving the prediction by hepatic venous pressure gradient?
    Park SH; Park HY; Kang JW; Park JS; Shin KJ; Kim CH; Suk KT; Baik GH; Kim JB; Kim DJ; Lee HY
    Hepatogastroenterology; 2012; 59(120):2548-51. PubMed ID: 23178621
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Nomogram to Predict the Risk of Stent Dysfunction After TIPS in Patients with Hepatitis B Cirrhosis.
    Zhan PC; Li Z; Li X; Lv PJ; Zhang YY; Yu P; Ji K; Shi Y; Ye SW; Xie BC; Gao JB; Zhou PL; Wu G
    Acad Radiol; 2022 Oct; 29(10):1532-1540. PubMed ID: 35216866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel nomogram model for predicting 6-week mortality in liver cirrhosis patients with acute upper gastrointestinal bleeding.
    Zhou YF; Xu Y; Ding YF; Yu XJ; Wu YL; Chen P; Zou DW
    J Dig Dis; 2022 Aug; 23(8-9):516-526. PubMed ID: 36208036
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis.
    Grønbaek H; Sandahl TD; Mortensen C; Vilstrup H; Møller HJ; Møller S
    Aliment Pharmacol Ther; 2012 Jul; 36(2):173-80. PubMed ID: 22591184
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis.
    Lens S; Alvarado-Tapias E; Mariño Z; Londoño MC; LLop E; Martinez J; Fortea JI; Ibañez L; Ariza X; Baiges A; Gallego A; Bañares R; Puente A; Albillos A; Calleja JL; Torras X; Hernández-Gea V; Bosch J; Villanueva C; Forns X; García-Pagán JC
    Gastroenterology; 2017 Nov; 153(5):1273-1283.e1. PubMed ID: 28734831
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liver fibrosis index-based nomograms for identifying esophageal varices in patients with chronic hepatitis B related cirrhosis.
    Xu SH; Wu F; Guo LH; Zhang WB; Xu HX
    World J Gastroenterol; 2020 Dec; 26(45):7204-7221. PubMed ID: 33362377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.